Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Perflow Medical

Explore full profile

Innovates cutting-edge neurovascular devices that advance the physician's unique skills and expertise by providing real-time control of the device during the procedure to improve overall performance…

Tel Aviv-Yafo, IsraelFounded 2010Biotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Perflow Medical and the history behind them.

About Perflow Medical

Perflow Medical, founded in 2010, is a medical device company headquartered in Netanya, Israel, that specializes in developing and commercializing neurovascular intervention technologies. The company was established by co-founders Danny Farin, Dr. Eyal Orion, Gilad Cibulski, and Avi Rappaport, originating from the RAD Biomed Incubator. CEO Danny Farin is a serial entrepreneur with a background in biotechnology engineering and finance, having previously co-founded and led Eon Surgical to a successful acquisition by Teleflex Medical. This experience in the medical device sector has been instrumental in guiding Perflow's strategic growth and commercialization efforts. In January 2022, Perflow Medical was acquired by a Chinese private equity fund for approximately $100 million, a move aimed at accelerating its global expansion.

Read full description

The company's core business revolves around its proprietary CEREBRAL NET™ technology platform, which features a braided net design that gives physicians real-time control over the device's diameter, length, and radial force during procedures. This platform is the foundation for its product portfolio, which targets neurovascular disorders, primarily ischemic and hemorrhagic strokes. Perflow's clients are hospitals and interventional neuroradiologists who perform complex procedures to treat conditions like brain aneurysms and remove blood clots. The company generates revenue through the sale of its medical devices in Europe, with plans for U.S. market entry pending FDA approval.

Perflow Medical's product line includes the Stream™ Dynamic Neuro-Thrombectomy Net and the Cascade™ Non-Occlusive Remodeling Net. The Stream™ family of products is designed for mechanical thrombectomy to treat acute ischemic stroke by effectively capturing and removing blood clots, even in smaller, more difficult-to-reach vessels. The Cascade™ devices are used for coil embolization of intracranial aneurysms. A key feature of the Cascade™ net is its non-occlusive design, which permits continuous blood flow during the procedure, a significant advantage over some traditional methods. These products have received CE Mark approval and are commercially available in Europe.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2010
Headquarters
Tel Aviv-Yafo, Israel
Employees
19
Open positions
None listed
Dealroom signal
68.9/100
Industry
Health, Legal
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Surgery, Neurology, Patient Care, Spinout, Hospital, Surgical Equipment
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jan 2022 $100M $100M Undisclosed ↗
EARLY VC✓Equity / VC Feb 2018 $12M $48M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Perflow Medical website traffic

Latest recorded traffic for Perflow Medical is 1.1K monthly website visits, up 266.7% over the last three months. Perflow Medical's team declined 9.5% over the past year.

Latest monthly visits1.1K 3-month web change+266.7% 1-year team growth-9.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors2 additional known investors

  • Technion Israel Institute of Technology
  • RAD BioMed
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇱 Israel50%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Perflow Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Perflow Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.